On the latest Talk Ya Book, Chris Judd welcomes back Andrew Chapman from Merchant Funds Management. Andrew talks us through bio-tech company Inoviq (ASX:IIQ), whose goal is to develop and commercialise a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases.

Merchant Funds Management specialise in small and micro-cap companies listed on the ASX.

Proudly presented by Honan (www.honan.com.au).

On the latest Talk Ya Book, Chris Judd welcomes back Andrew Chapman from Merchant Funds Management. Andrew talks us through bio-tech company Inoviq (ASX:IIQ), whose goal is to develop and commercialise a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases.
Merchant Funds Management specialise in small and micro-cap companies listed on the ASX.
Proudly presented by Honan (www.honan.com.au).

Talk Ya Book shines a light on the investment processes used by Australia's best investors as they talk through their highest conviction investment idea. 

Talk Ya Book shines a light on the investment processes used by Australia's best investors as they talk through their highest conviction investment idea.&nbsp;

Chris Judd's Talk Ya Book Podcast

Chris Judd's Talk Ya Book

Andrew Chapman

On today's Talk Ya Book, John Van Der Wielen discusses Orthocell, a medical device company. With substantial global market potential, especially in the U.S., Orthocell's innovative nerve repair solution offers hope for patients. The company's strong leadership and strategic focus position it well for significant growth.

Proudly presented by Honan (www.honan.com.au).

On today's Talk Ya Book, John Van Der Wielen discusses Orthocell, a medical device company. With substantial global market potential, especially in the U.S., Orthocell's innovative nerve repair solution offers hope for patients. The company's strong leadership and strategic focus position it well for significant growth.
Proudly presented by Honan (<a href="https://www.honan.com.au">www.honan.com.au</a>).

John Van Der Wielen

Emanuel Datt highlights Predictive Discovery (PDI) as a promising gold stock. PDI's Guinea project boasts over 5 million ounces of resources and a strong financial profile. The current favourable gold market, coupled with upcoming milestones like the definitive feasibility study and exploitation permit, could significantly enhance the project's value.

 Proudly presented by Honan (www.honan.com.au).

Emanuel Datt highlights Predictive Discovery (PDI) as a promising gold stock. PDI's Guinea project boasts over 5 million ounces of resources and a strong financial profile. The current favourable gold market, coupled with upcoming milestones like the definitive feasibility study and exploitation permit, could significantly enhance the project's value.
 Proudly presented by Honan (<a href="https://www.honan.com.au">www.honan.com.au</a>).

Emanuel Datt

Luke Laretive from Seneca Financial Solutions talks us through Wildcat Resources, a lithium exploration company. With a strong management team and attractive valuation, Wildcat is well-positioned to capitalise on the growing demand for lithium. The company's recent performance and promising project pipeline have attracted significant investor interest.

Proudly presented by Honan (www.honan.com.au).

Luke Laretive from Seneca Financial Solutions talks us through Wildcat Resources, a lithium exploration company. With a strong management team and attractive valuation, Wildcat is well-positioned to capitalise on the growing demand for lithium. The company's recent performance and promising project pipeline have attracted significant investor interest.
Proudly presented by Honan (<a href="http://www.honan.com.au">www.honan.com.au</a>).

Andrew Chapman

In 1 playlist(s)

Chris Judd's Talk Ya Book

Follow podcast

Recent clips